Skip to main content
Log in

Bactericidal Activity of Liposomal Form of Lytic Mycobacteriophage D29 in Cell Models of Tuberculosis Infection In Vitro

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The use of lytic mycobacteriophages to treat tuberculosis under conditions of acquired resistance to anti-tuberculosis drugs is one of the most practical ways to improve the effectiveness of therapy and reduce the spread of this disease. We studied the efficacy of antimycobacterial action of mycobacteriophage D29 encapsulated into 400-nm liposomes in cell models of tuberculosis infection in vitro. The antimycobacterial action of lytic mycobacteriophage D29 used in free or liposome-encapsulated forms was demonstrated on cell models of intracellularly infected RAW264.7 macrophages and tuberculous granuloma formed by human blood mononuclear cells. The experiments demonstrated pronounced advantage of liposomal form of mycobacteriophage according to the criteria of their penetration into macrophages and lysis of Mycobacterium tuberculosis in culture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lapenkova MB, Smirnova NS, Rutkevich PN, Vladimirsky MA. Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M. tuberculosis-Infected Macrophage RAW 264 Cell Line. Bull. Exp. Biol. Med. 2018; 164(3):344-346. doi: https://doi.org/10.1007/s10517-018-3986-0

    Article  CAS  Google Scholar 

  2. Adriaenssens EM, Lehman SM, Vandersteegen K, Vandenheuvel D, Philippe DL, Cornelissen A, Clokie MR, García AJ, De Proft M, Maes M, Lavigne R. CIM(®) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology. 2012 Dec 20;434(2):265-70. doi: https://doi.org/10.1016/j.virol.2012.09.018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cebriá-Mendoza M, Sanjuán R, Domingo-Calap P. Directed Evolution of a Mycobacteriophage. Antibiotics (Basel). 2019;8(2). pii: E46. doi: https://doi.org/10.3390/antibiotics8020046

  4. Hatfull GF. Mycobacteriophages: windows into tuberculosis. PLoS Pathog. 2014;10(3). e1003953. doi: https://doi.org/10.1371/journal.ppat.1003953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kiran D, Podell BK, Chambers M, Basaraba RJ. Host-directed therapy targeting the Mycobacterium tuberculous granuloma: a review. Semin. Immunopathol. 2016;38(2):167-83. doi: https://doi.org/10.1007/s00281-015-0537-x

    Article  CAS  PubMed  Google Scholar 

  6. Lin DM, Koskella B, Lin HC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 2017;8(3):162-173. doi: https://doi.org/10.4292/wjgpt.v8.i3.162

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nieth A, Verseux C, Barnert S, Süss R, Römer W. A first step toward liposome-mediated intracellular bacteriophage therapy. Expert Opin. Drug Deliv. 2015;12(9):1411-1424. doi: https://doi.org/10.1517/17425247.2015.1043125

    Article  PubMed  Google Scholar 

  8. Nilsson AS. Phage therapy--constraints and possibilities. Ups. J. Med. Sci. 2014;119(2):192-198. doi: https://doi.org/10.3109/03009734.2014.902878

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M. The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Front. Immunol. 2018;9:155. doi: https://doi.org/10.3389/fimmu.2018.00155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Singla S, Harjai K, Katare OP, Chhibber S. Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies. PLoS One. 2016;11(4). e0153777. doi: https://doi.org/10.1371/journal.pone.0153777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. A. Vladimirsky.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 3, pp. 334-337, March, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapenkova, M.B., Alyapkina, Y.S. & Vladimirsky, M.A. Bactericidal Activity of Liposomal Form of Lytic Mycobacteriophage D29 in Cell Models of Tuberculosis Infection In Vitro. Bull Exp Biol Med 169, 361–364 (2020). https://doi.org/10.1007/s10517-020-04887-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-04887-6

Key Words

Navigation